Mainstream

CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8%

CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8%

Post ContentcrgxRead More

You might also be interested in reading Wazirx Preps for Relaunch With Zodia Custody, Backed by Banking Powerhouses.

July 8, 2025
In Mainstream